ArticleMolecular cancer therapeutics2026

LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

Anh Minh Tran Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.